Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s224, 2023. DOI: 10.25251/skin.7.supp.224. Disponível em: https://skin.dermsquared.com/skin/article/view/2186. Acesso em: 19 may. 2025.